|Articles|May 5, 2003
Comparative study finds early vision benefits for intravitreal triamcinolonetreatment of occult CNV
Ft. Lauderdale-Results from a prospective, comparative study indicateintravitreal triamcinolone acetonide 25 mg may improve visual outcome insome patients with exudative AMD, reported Jost B. Jonas, MD, of the Universityof Heidelberg, Germany.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses
2
Evolving glaucoma therapy: A new era of interventional strategies
3
Throwback Series: Managing bilateral diabetic macular edema early in practice
4
ICYMI: AAO 2025 showcases new technologies and continued research
5













































.png)


